BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
35.46
+1.21 (3.53%)
At close: Jun 2, 2025, 4:00 PM
34.77
-0.69 (-1.95%)
After-hours: Jun 2, 2025, 5:16 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $6.73 billion as of June 2, 2025. Its market cap has increased by 24.29% in one year.
Market Cap
6.73B
Enterprise Value
8.02B
1-Year Change
24.29%
Ranking
Category
Stock Price
$35.46
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $6.73B, an increase of 102.82%. That is a compound annual growth rate of 12.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |